Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 18 studies | 26% ± 12% | |
| natural killer cell | 13 studies | 22% ± 6% | |
| non-classical monocyte | 13 studies | 27% ± 12% | |
| oligodendrocyte precursor cell | 12 studies | 32% ± 10% | |
| astrocyte | 12 studies | 41% ± 15% | |
| microglial cell | 12 studies | 33% ± 10% | |
| macrophage | 11 studies | 30% ± 11% | |
| GABAergic neuron | 10 studies | 43% ± 24% | |
| CD16-negative, CD56-bright natural killer cell, human | 9 studies | 21% ± 4% | |
| CD16-positive, CD56-dim natural killer cell, human | 9 studies | 24% ± 8% | |
| glutamatergic neuron | 9 studies | 49% ± 26% | |
| oligodendrocyte | 9 studies | 27% ± 13% | |
| epithelial cell | 7 studies | 22% ± 7% | |
| pericyte | 7 studies | 28% ± 14% | |
| myeloid cell | 7 studies | 24% ± 5% | |
| dendritic cell | 7 studies | 29% ± 6% | |
| classical monocyte | 6 studies | 21% ± 9% | |
| interneuron | 6 studies | 50% ± 24% | |
| adipocyte | 6 studies | 23% ± 3% | |
| fibroblast | 6 studies | 27% ± 3% | |
| mast cell | 6 studies | 26% ± 7% | |
| monocyte | 6 studies | 36% ± 15% | |
| smooth muscle cell | 6 studies | 21% ± 5% | |
| endothelial cell of lymphatic vessel | 5 studies | 26% ± 4% | |
| neuron | 4 studies | 32% ± 13% | |
| ciliated cell | 4 studies | 27% ± 8% | |
| lymphocyte | 4 studies | 27% ± 8% | |
| amacrine cell | 4 studies | 27% ± 7% | |
| retina horizontal cell | 4 studies | 27% ± 9% | |
| T cell | 4 studies | 20% ± 4% | |
| conventional dendritic cell | 3 studies | 35% ± 16% | |
| hematopoietic precursor cell | 3 studies | 24% ± 8% | |
| GABAergic interneuron | 3 studies | 35% ± 6% | |
| granule cell | 3 studies | 31% ± 6% | |
| GABAergic amacrine cell | 3 studies | 31% ± 11% | |
| glycinergic amacrine cell | 3 studies | 24% ± 4% | |
| retinal cone cell | 3 studies | 32% ± 12% | |
| retinal rod cell | 3 studies | 21% ± 1% | |
| ependymal cell | 3 studies | 36% ± 9% | |
| B cell | 3 studies | 25% ± 7% | |
| alveolar macrophage | 3 studies | 25% ± 6% | |
| type I pneumocyte | 3 studies | 19% ± 4% | |
| transit amplifying cell | 3 studies | 36% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| uterus | 100% | 486.69 | 170 / 170 | 100% | 5.36 | 457 / 459 |
| esophagus | 100% | 396.88 | 1445 / 1445 | 99% | 3.87 | 182 / 183 |
| brain | 100% | 510.05 | 2633 / 2642 | 100% | 3.37 | 703 / 705 |
| lung | 100% | 535.19 | 577 / 578 | 99% | 3.48 | 1148 / 1155 |
| breast | 100% | 502.45 | 459 / 459 | 99% | 4.25 | 1109 / 1118 |
| thymus | 100% | 470.90 | 653 / 653 | 98% | 3.12 | 595 / 605 |
| bladder | 100% | 446.86 | 21 / 21 | 98% | 3.85 | 495 / 504 |
| pancreas | 99% | 272.44 | 326 / 328 | 98% | 3.28 | 174 / 178 |
| adrenal gland | 100% | 338.18 | 258 / 258 | 97% | 3.19 | 222 / 230 |
| intestine | 100% | 438.07 | 966 / 966 | 96% | 3.44 | 507 / 527 |
| stomach | 100% | 332.38 | 358 / 359 | 95% | 3.31 | 273 / 286 |
| ovary | 100% | 565.59 | 180 / 180 | 93% | 2.19 | 402 / 430 |
| skin | 100% | 563.93 | 1805 / 1809 | 94% | 4.30 | 442 / 472 |
| kidney | 100% | 315.63 | 89 / 89 | 93% | 2.68 | 841 / 901 |
| prostate | 100% | 378.62 | 244 / 245 | 93% | 2.01 | 468 / 502 |
| liver | 95% | 178.15 | 215 / 226 | 53% | 1.03 | 217 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 5.40 | 29 / 29 |
| spleen | 100% | 1035.63 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 5.65 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.31 | 1 / 1 |
| adipose | 100% | 517.61 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 410.20 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 1102.92 | 923 / 929 | 0% | 0 | 0 / 0 |
| heart | 98% | 306.18 | 841 / 861 | 0% | 0 | 0 / 0 |
| muscle | 81% | 123.14 | 653 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 71% | 1.95 | 57 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0045162 | Biological process | clustering of voltage-gated sodium channels |
| GO_0060271 | Biological process | cilium assembly |
| GO_0005814 | Cellular component | centriole |
| GO_0005813 | Cellular component | centrosome |
| GO_0097539 | Cellular component | ciliary transition fiber |
| GO_0005829 | Cellular component | cytosol |
| GO_0071439 | Cellular component | clathrin complex |
| GO_0030276 | Molecular function | clathrin binding |
| GO_0017080 | Molecular function | sodium channel regulator activity |
| Gene name | SCLT1 |
| Protein name | Sodium channel and clathrin linker 1 (Sodium channel-associated protein 1) Sodium channel and clathrin linker 1 |
| Synonyms | SAP1 |
| Description | FUNCTION: Adapter protein that links SCN10A to clathrin. Regulates SCN10A channel activity, possibly by promoting channel internalization (By similarity). . |
| Accessions | ENST00000281142.10 [Q96NL6-1] ENST00000439369.6 [Q96NL6-3] D6RDM2 ENST00000506368.5 D6RBA6 ENST00000503215.5 Q96NL6 D6RBP0 ENST00000503401.1 ENST00000651532.1 ENST00000511426.5 [Q96NL6-4] A0A494C0G8 |